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Abstract
Objectives The current reference standard for diagnosing LAA thrombi is transesophageal echocardiography (TEE), a semi-
invasive technique. We aimed to devise an optimal protocol for cardiac computed tomography (CCT) in diagnosing left atrial
appendage (LAA) thrombus in patients with atrial fibrillation (AF), using TEE as reference standard.
Methods Two hundred sixty consecutive patients referred for radiofrequency ablation for AF were prospectively enrolled. All
patients underwent CCT and TEEwithin 2 hours. The CCT protocol included one standard angiographic phase and three delayed
acquisitions at 1-, 3-, and 6-min after contrast injection. Thrombi were defined as persisting defects at 6-min delayed acquisition.
Results TEE demonstrated spontaneous contrast in 52 (20%) patients and thrombus in 10 (4%). In 63 patients (24%), CCT
demonstrated LAA early filling defects at angiographic phase. Among them, 15 (6%) had a persistent defect at 1-min, 12 (5%) at
3-min, and 10 (4%) at 6-min. All 10 thrombi diagnosed on TEE were correctly identified by delayed CCT, without any false
positives. For all phases, sensitivity and negative predictive were 100%. Specificity increased from 79% for the angiographic
phase to 100% at 6-min. Positive predictive value increased from 16% to 100%. Estimated radiation exposure was 2.08 ±
0.76 mSv (mean ± standard deviation) for the angiographic phase and 0.45 ± 0.23 mSv for each delayed phase.
Conclusion A CCT protocol adding a 6-min delayed phase to the angiographic phase can be considered optimized for the
diagnosis of LAA thrombi, with a low radiation dose.
Key Points
• In patients with persistent atrial fibrillation referred for ablation procedures, a cardiac CT examination comprising an
angiographic-phase acquisition and, in case of filling defects, a 6-min delayed phase may help reduce the need for trans-
esophageal echocardiography.
• Cardiac CT would provide morphological and volumetric data, along with the potential to exclude the presence of thrombi in
the left atrial appendage.
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Cardiac computed tomography (CCT) is a well-established
technique for the evaluation of left atrial and pulmonary vein
anatomy [1, 2]. CCT images may be integrated with electro-
physiological mapping to guide radiofrequency catheter abla-
tion of atrial fibrillation (AF) [3]. In addition, CCT has been
regarded as an emerging noninvasive imaging modality for
the detection of left atrial appendage (LAA) thrombus, which
is mandatory before radiofrequency catheter ablation for re-
ducing the risk of subsequent thromboembolic events [4, 5].
Although CCT is a highly sensitive modality for excluding
intracardiac thrombi, early-phase imaging cannot allow to vi-
sually distinguish circulatory stasis from thrombus in the LAA
or other cardiac locations, resulting in low specificity and
positive predictive value [6–8]. In fact, apparent filling defects
on CCT do not always correspond to a thrombus and may
represent sludge or severe spontaneous contrast anomalies
due to circulatory stasis.
Previous studies have demonstrated an improved diagnos-
tic accuracy of CCT in LAA thrombus diagnosis when an
additional delayed acquisition is performed [9, 10].
However, the results are conflicting and the diagnostic accu-
racy varied widely between reports, preventing the achieve-
ment of a definite conclusion and limiting the use of CCT in
routine practice in this setting [9, 11, 12]. Moreover, there was
a large variability in reported delay times for the late-phase
acquisition, ranging from 30 seconds to 3 min, leading to
discrepancies between reported specificities and positive pre-
dictive values (PPVs).
In this scenario, transesophageal echocardiography (TEE)
is considered the standard of care and it is recommended by
international guidelines as the only imaging modality for di-
agnosing LAA thrombus [13, 14], especially in patients with
persistent AF, even though it is a semi-invasive test [15, 16].
The purpose of our study was to evaluate the diagnostic
performance of delayed CCT scans in diagnosing LAA
thrombus in a cohort of consecutive patients with persistent
AF referred for radiofrequency ablation, and to determine the
optimal delay time acquisition to a differentiate between




Our institutional review board, the Ethics Committee of
Ospedale San Raffaele, approved the study (study protocol
HSR Late, approved on October 10, 2010), and from
December 2010 to March 2013, 260 consecutive patients
(199 men (77%), mean age of 59 ± 11 years, range 25–83
years) with drug-refractory, symptomatic, and persistent AF
scheduled for radiofrequency catheter ablation using the
CARTO (Biosense Webster) or NAVX (St. Jude Medical)
system were prospectively enrolled in this study. On the day
before radiofrequency catheter ablation, all patients
underwent both routine TEE screening and CCT for anatom-
ical evaluation of the left atrium and pulmonary veins, within
a 2-hour interval. Exclusion criteria were renal insufficiency
(estimated glomerular filtration rate < 30 ml/min), a docu-
mented history of anaphylactic reaction to iodinated contrast
agent, pregnancy, and the presence of paroxysmal AF. All
participating patients provided written informed consent.
All patients were included in an electronic database, all
clinical and imaging characteristics were recorded, and the
CHADS2 score [17] was calculated.
CCT protocol
All patients were examined with a 64-slice CT scanner
(LightSpeed VCT XTe scanner, GE Healthcare). No beta-
blockers were used for regulation of heart rate in any of the
enrollees. The imaging protocol consisted of a standard
angiographic-phase acquisition to evaluate left atrium and pul-
monary vein anatomy and three delayed-phase acquisitions at
1-, 3-, and 6-min after contrast material injection, to differen-
tiate thrombus, defined as a persisting defect at 6-min delayed
acquisition, from early filling artifacts. The late-phase scan-
ning was performed only if a filling defect (defined as an
incomplete visualization or opacification of the entire LAA)
was detected in the angiographic phase or if persisted in the 1-
or 3-min delayed acquisition.
For the angiographic phase, an electrocardiography (ECG)-
assisted scan with prospective gating centered at 75% of the
R-R interval was performed within a single breath-hold, cov-
ering a range from the aortic arch to the heart base. Tube
voltage and current were adapted to patients’ bodymass index
(100 kVp for patients with a body mass index below or equal
to 30 kg/m2, and 120 kVp for patients whose bodymass index
was above 30 kg/m2, tube current from 350 to 770 mA),
rotation time was 350 ms, and slice thickness was 0.6 mm.
A nonionic, iso-osmolar contrast material (iodixanol,
320 mg of iodine per ml, Visipaque 320; General Electric
Healthcare) was administered intravenously at the dose of
80–100 ml, followed by 50 ml of saline solution, at a rate of
5 ml/s by using a dual-shot injector (Nemoto Kyorindo).
Visual bolus tracking was performed, and scanning was
started when the contrast completely filled the LA.
To minimize unnecessary radiation exposure, delayed
scans were limited to the LAA; the 1-min scan was performed
only when a LAA filling defect was found at a quick review of
the obtained images on the angiographic phase, the 3-min scan
when it persisted at 1-min, and the 6-min scan if it persisted at
3-min. All the delayed acquisitions were performed with
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prospective ECG gating, reduced tube voltage, and current
(80–100 kVp, 350–500 mA) and were limited to the LA, in
order to further minimize the radiation dose. Particular atten-
tion was paid to include the entire LAA in a single slab to
avoid possible step artifacts [18]. All CCT images were recon-
structed using the adaptive statistical iterative reconstruction
(ASIR, General Electric) algorithm (40% filtered back-
projection blending) to enable radiation dose reduction with-
out affecting the overall image quality [19].
Images were reconstructed using a soft-tissue convolution
kernel.
The scanning length and time as well as the dose length
product (DLP) of the CCT were noted from the scanner con-
sole, and the effective radiation dose of the different phases
was calculated by multiplying the DLP times a conversion
factor (0.014 mSv/cGy/cm), as previously suggested [20].
Image analysis
Images were transferred to an external workstation (Aquarius
Intuition; TeraRecon). Two independent radiologists with 14
and 9 years of experience in cardiovascular imaging, blinded
to all patients’ data, qualitatively evaluated the presence of
LAA filling defects on both angiographic and delayed scans.
The persistence of a LAA filling defect on the last 6-min
delayed CCT phase was considered as indicative of the pres-
ence of LAA thrombus whereas a disappearance of the filling
defect at 1-, 3-, or 6-min suggested the presence of slow-flow
effect and pseudo-filling defects. Differences in the assess-
ment by the readers were resolved by consensus.
For each patient, anatomy of the left atrium and the pulmo-
nary veins and left atrium volume were evaluated in the
angiographic-phase images. On the day of pulmonary vein
isolation, 3D CCT images were reconstructed on a separate
workstation and integrated with electro-anatomical mapping.
Transesophageal echocardiography
All patients underwent TEE examination using a GEVivid E9
(GE Healthcare) ultrasound system equipped with 6VT-D
probes, respectively. A complete 2D, colored, pulsed, and
continuous-wave Doppler echocardiogram was performed ac-
cording to EACVI recommendations [13]. The exams were
digitally stored and transferred on external workstation for
offline analysis (EchoPAC, version 201).
TEE allows the following information: (1) a 2D multiplane
or 3D analysis of LA and LAA anatomy, (2) a semi-
quantitative classification of the degree of spontaneous echo
contrast, and (3) a Doppler measurement of the LAA empty-
ing flows.
Spontaneous echocardiographic contrast was defined as an
intracavitary swirling smoke-like echo within the left atrium
or LAA that could not be eliminated by altering the gain
settings, and it was classified as mild to moderate, severe,
and sludge (dense smoke, viscid echodensity, not solid)
[21]. LAA thrombus was defined as a solid, well-
circumscribed mass that was visible throughout the cardiac
cycle [22].
Two experienced cardiologists blinded to CCT and clinical
data reviewed all TEE images. Differences in assessments by
the observers were resolved by consensus.
A thrombus was defined as a circumscribed echogenic or
echolucent mass distinct from the surrounding atrial wall.
Spontaneous echocardiographic contrast was defined as an
intracavitary swirling smoke-like echo within the left atrium
or LAA that could not be eliminated by altering the gain
settings. Spontaneous echocardiographic contrast severity
was classified using a 4-grade scale based on appearance
and density (none, mild, moderate, or severe), as previously
described [23, 24].
Statistical analysis
All statistical analyses were performed using SPSS, version
17.0 (SPSS, Inc.). Normally or near-normally distributed con-
tinuous variables were expressed asmean ± standard deviation
and categorical variables as frequencies or percentages.
Ninety-five percent confidence intervals (CI) were calculated
according the binomial distribution.
Using TEE as the reference standard, the diagnostic perfor-
mance for diagnosing LAA thrombus of early- and delayed-
phase CCTs was calculated from contingency tables. DLP
(mGy × cm) of all examinations was recorded, and the effec-
tive radiation exposures, estimated in mSv, were compared
between patients with and without thrombus or circulatory
stasis by Student’s t test for independent samples. Inter-
reader reproducibility was appraised with Cohen’s κ and cal-
culating raw concordance. Cohen’s κ was interpreted accord-
ing to guidelines by Koo and Li [25]. A p value < 0.05 was
considered statistically significant.
Results
The clinical characteristics of the overall study population are
summarized in Table 1. A total of 260 consecutive patients
were enrolled in the study, and no enrolled patient was ex-
cluded according to exclusion criteria. Out of all patients, 119
(46%) had a CHADS2 score of 0, 124 (48%) had a CHADS2
score of 1, and 17 (6%) had a CHADS2 score ≥ 2. All patients
underwent CCT and TEE without complications. All patients
were in AF during CCT images acquisition. The average heart
rate was 86 ± 25 (range 66–114). In all cases, image quality
was technically adequate for clinical assessment.
Of 260 patients, 10 (4%, 95% CI 2–7%) were diagnosed
with thrombi and 52 (20%, 95% CI 15–25%) with
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spontaneous echocardiographic contrast (35 mild, 14 moder-
ate, and 3 severe) without thrombus on TEE. All thrombi were
located in the LAA.
As depicted on the CCT, 63/260 patients (24%) presented
with LAA early filling defects on the angiographic acquisition.
Of these, 15/260 (6%) had a LAA persistent filling defect at 1-
min and underwent 3-min delayed acquisition. Then, 12/260
(5%) patients still had a pseudo-filling defects at 3-min, so the
6-min delayed acquisition was performed. The remaining 10/
260 (4%) filling defects were persistent on the last 6-min de-
layed scan and were diagnosed as thrombus (Figs. 1, 2, and 3).
Interobserver agreement was excellent (κ = 0.950, p <
0.001), and so was raw concordance (99.7%). In one case,
there was disagreement between the two readers; in that case,
consensus was achieved at a joint reading and final diagnosis
was no filling defects.
TEE and CCT results are summarized in Table 2.
Sensitivity, specificity, PPV, and negative predictive value
(NPV) of CCT at all phases using TEE as a reference standard
are reported in Table 3, while Fig. 4 depicts their changes.
The estimated radiation dose was 2.08 ± 0.76 mSv (1.19–
5.11 mSv) for angiographic imaging and 0.45 ± 0.23 mSv
(0.18–1.08 mSv) for every single late-phase scan.
Considering all patients, the mean radiation dose of the com-
plete CT examination was 2.17 ± 0.91 mSv (1.19–5.71 mSv),
while the maximum radiation dose estimated in patients who
underwent all delayed-phase scans (n = 12, 5%) was 3.29 ±
1.05 mSv (1.90–5.71 mSv). The total radiation exposure was
significantly higher for patients with thrombus (3.29 ± 1.05
mSv) comparedwith both patients without early filling defects
(2.08 ± 0.76 mSv) and with circulatory stasis (2.29 ± 0.92
mSv) (p < 0.001 and p = 0.003, respectively). Conversely,
no significant differences in radiation exposure were noted
between patients with circulatory stasis and without early fill-
ing defects (p = 0.080).
Discussion
Over the last years, the role of CCT in assessing LAA throm-
bus has been supported by a growing number of reports,
showing that it is a potentially useful imaging modality, dis-
tinctly when delayed-imaging acquisition protocols are used
[24, 26, 27].
A meta-analysis published by Romero et al [9] demonstrat-
ed that the use of a two-phase strategy, including delayed
imaging, significantly improves CCT diagnostic specificity,
leading to a pooled PPV of 92% compared with a PPV of
41% for the angiographic phase, while the NPV remains ex-
cellent (approximately 100%). These results are consistent
with the more recent retrospective study by Lazoura et al
[28] who obtained both a specificity and a PPV of 100% by
experimenting a 60-s delayed CCT acquisition in 122 patients
undergoing left atrial intervention for AF, using TEE as refer-
ence standard. Hence, the addition of a delayed acquisition
strongly reduced CCT false positive rates since a longer time
is available for the contrast media to fill the entire LAA, there-
by yielding greater contrast opacification and improving dif-
ferentiation of thrombus from circulatory stasis.
Fig. 1 Axial cardiac images of a 70-year-old man. a Early-phase CCT
image demonstrated a filling defect in LAA (black arrowhead). b CCT
image 1-min after contrast injection demonstrated no filling defects in
LAA.No further acquisitions were needed. c TEE image obtained 2 hours
after CCT demonstrated moderate spontaneous echographic contrast with
no thrombus in LAA
Table 1 Baseline characteristics of the study population
Variable Values (n = 260)
Age (years), mean ± SD (range) 59 ± 11 (25–83)
Males, n (%) 199 (77)
Body mass index (kg/m2), mean ± SD (range) 27.2 ± 5.1 (17.8–49.1)
Hypertension, n (%) 133 (51)
Diabetes mellitus, n (%) 16 (6)
Hyperlipidemia, n (%) 71 (27)
Ejection fraction ≤ 55%, n (%) 21 (8)
Previous TIA/stroke, n (%) 7 (3)
Mean CHADS2, mean ± SD (range) 0.6 ± 0.6 (0–3)
TIA transient ischemic attack; CHADS2 Congestive Heart Failure,
Hypertension, Age > 75 years, Diabetes and Prior Stroke
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Fig. 2 Axial cardiac images of a
58-year-old woman. a Early-
phase CCT image demonstrated a
filling defect in LAA (black ar-
rowhead), persisting in the late-
phase CCT image 1 min after
contrast injection (b). c The fol-
lowing scan at 3-min did not
confirm the filling defect. d TEE
image obtained 2 hours after CCT
image acquisition demonstrated
severe spontaneous echographic
contrast with no thrombus in
LAA
Fig. 3 Axial cardiac images of a 53-year-old man. a Early-phase CCT
image demonstrated a large filling defect in LAA (black arrowhead) with
a small persisting quote in both the multiple late-phase scans performed
(b–d), suggestive of thrombus in LAA. e TEE image obtained 1 h after
CCT confirmed LAA thrombosis (white arrow)
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Despite the promising diagnostic performance of the two-
phase CCT protocol, there were no data from human or animal
studies about the basis of a correct scan timing for the late-
phase acquisition. Variable delay times were reported, ranging
from 30 s to 2 or 3 min, leading to discrepancies between
reported specificities or PPVs, particularly in patients who
were in AF at the time of the study.
Moreover, the suboptimal diagnostic performance of CCT
in this setting is partly due to a high heterogeneity of popula-
tions (heterogeneous cohorts of patients with different risk
profiles and prevalence of thrombosis), different time intervals
between CCT and TEE, and no clear cutoff value for CCT
quantitative analysis [9, 12]. As a consequence, to date, CCT
has not been included in practice guidelines for evaluation of
patients with AF, even if this modality is performed before AF
ablation for anatomical left atrium characterization and could
be implemented to diagnose LAA thrombus before the proce-
dure. Thus, a standardization of the delayed-phase CCT pro-
tocol is desirable.
In this clinical experience, we found that even 3-min delay
for dual-phase CCT is not always appropriate to differentiate
thrombus from circulatory stasis, still leading to false positive
cases. We hypothesize that this might result from the slow-
flow artifacts related to the physio-pathological aspects of per-
sistent AF and LAA dysfunction. In fact, contrast
opacification may take longer in these patients. For these rea-
sons, we studied a selected population of patients with persis-
tent AF. On the other hand, we prolonged the delay of the late-
phase scan to completely eliminate filling defects related to
slow-flow states, while maintaining a vascular attenuation
high enough to allow thrombus detection.
Therefore, our study was designed to derive the optimal
delay time for use in real-world clinical practice. Differently
from other investigations, our data were obtained in a large
and homogeneous population of candidates to radiofrequency
catheter ablation, all with persistent AF. Patients with parox-
ysmal AF were excluded from our study because of their
demonstrated very low incidence of both pseudo-filling de-
fects and LAA thrombosis, making TEE unnecessary before a
planned AF ablation [29]. To improve the robustness of the
study, we minimized the interval between TEE, CCT, and
pulmonary vein isolation through close collaboration with
cardiologists.
Our main findings are that 5 persistent filling defects (33%)
at 1-min delay scan and 2 (17%) at 3-min delay scan, respec-
tively, disappeared at 6-min delayed acquisition and would
have been falsely diagnosed as LAA thrombus, resulting in
suboptimal PPVs of 67 and 83%, respectively.
Considering the 6-min delayed acquisition, both sensi-
tivity and PPV increased to 100%, while maintaining an
optimal delineation of thrombus dimensions and morphol-
ogy, fully comparable with TEE results. Other options for
technical adjustments to improve LAA thrombus detection
described in previous studies include a biphasic iodine bo-
lus technique [30]. However, while this method has the
advantage of allowing for shorter scan times, it still pre-
sents a higher rate of false positives compared to the 6-min
delayed acquisition.
Similarly to other investigations, our study reaffirms that
the prevalence of LAA thrombosis in candidates to pulmonary
vein isolation is low (4%), as the majority of these patients are
anticoagulated and have a low prevalence of CHADS2 score
Table 2 Concordance between delayed-contrast cardiac computed to-
mography and transesophageal echocardiography for the detection of left
atrial appendage thrombus
CCT TEE (n = 260), n (%)
Thrombus No thrombus
Angiographic phase
Filling defect 10 (4) 53 (20)
No filling defect 0 197 (76)
1-min delay
Filling defect 10 (4) 5 (2)
No filling defect 0 245 (94)
p value with previous timing < 0.001
3-min delay
Filling defect 10 (4) 2 (1)
No filling defect 0 248 (95)
p value with previous timing 0.437
6-min delay
Filling defect 10 (4) 0
No filling defect 0 250 (96)
p value with previous timing 0.663
Table 3 Diagnostic accuracy
parameters for scans acquired at
different timings post contrast
injection
Sensitivity Specificity Positive predictive value Negative predictive value
Angiography 100 (69–100) 79 (73–84) 16 (8–27) 100 (98–100)
1-min delay 100 (69–100) 98 (95–99) 67 (38–88) 100 (99–100)
3-min delay 100 (69–100) 99 (97–100) 83 (52–98) 100 (99–100)
6-min delay 100 (69–100) 100 (99–100) 100 (69–100) 100 (99–100)
Data are reported as value (%) and 95% confidence interval
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≥ 2 (6%). Our large sample size (260 patients) makes this
estimation relatively precise (95% CI 2–7%)
Our study has some limitations. First, the use of addi-
tional late-phase acquisitions caused an increased radiation
exposure. However, we minimized radiation burden by
using body mass index–adapted current and voltage modu-
lation and prospective ECG triggering for both angiograph-
ic and delayed scans. In addition, unenhanced scan and
calcium scoring were not performed and the delayed scans
were performed only in a small number of patients and
limited to the left atrium (delivering only 0.45 ± 0.23 mSv
additional dose). The resultant effective radiation burden
was thus acceptable and in line with recent publications.
In clinical practice, using only the angiographic acquisition
and the 6-min scan limited to the LA, full diagnostic infor-
mation can be obtained with a low radiation exposure.
Second, we considered TEE as a reference standard even
though it is heavily operator dependent and has suboptimal
diagnostic accuracy in LAA assessment. Because of the
complex anatomic features of thrombi, they can be difficult
to detect and thus missed while a false positive diagnosis
can result from misinterpretation of heavy spontaneous
echo contrast or pectinate muscles as thrombi. Hence, even
though TEE is the standard of care in this setting, future
prospective studies of CCT using surgical or pathologic
reference standard are desirable. Moreover, our selection
of CCT delay times (1-, 3-, and 6-min) was arbitrary, based
on our previous clinical experience. The optimal delay time
can vary widely according to different factors, as well the
severity of left atrium and LAA dysfunction and the
contrast injection protocol (intravenous injection rate, total
injection volume, saline flush). Another limitation of our
study is the fact that we did not include a quantitative anal-
ysis of CCT scans, and only a qualitative assessment was
performed. This was due to this work, a preliminary, visual
analysis that could be easily integrated into clinical practice
of findings stemming from delayed phases concerning
LAA thrombus detection. Further studies including quanti-
tative analyses and possibly aiming to contrast agent dose
reduction and optimization will be performed [31].
In conclusion, we showed that CCT protocol including
delayed phases is highly accurate for diagnosing LAA throm-
bosis and may obviate TEE in patients undergoing CCT for
ablation procedures. Because the 1- and 3-min phases are still
influenced by circulatory stasis leading to false positives,
adding a 6-min delayed phase to the angiographic phase can
be considered an optimized CCT protocol in this setting, with
an overall radiation dose lower than 3 mSv. A dual (early and
6-min) phase CCT might represent the modality of choice to
exclude LAA thrombus before AF catheter ablation. Given
the very low prevalence of LAA thrombus, the vast majority
of patients will have a negative test, waiving the need for
routine TEE. Future multicenter studies are needed to prove
the effectiveness of this approach.
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Fig. 4 Diagnostic performance of different CCT phases, expressed as sensibility, specificity, positive predictive value (PPV), and negative predictive
value (NPV)
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